Complementing Cois Coiribe‘s article on Finding Ways to Live Well as We Age from Prof Abhay Pandit, Founding Director of CÚRAM, this spotlight feature on Dr Eoin McEvoy explores his unique research and motivations. Read on to find out more about both his academic insight as well as his vision for the years to come.
Dr Eoin McEvoy is part of the School of Engineering, College of Science and Engineering, Biomedical Engineering and CÚRAM Research Ireland Centre for Medical Devices.
Hi, my name is Eoin, and I am an Associate Professor in Biomedical Engineering. Our work focuses on the development of advanced computational and experimental models that provide new understanding of cell and tissue remodelling in cancer and immune-mediated disease, motivating novel mechano-therapeutics and treatment strategies.
I currently lead an European Research Council-funded project to investigate the mechanobiology of tumour growth and therapy resistance. Within this space, we hope to develop a personalised framework to predict patient-specific outcomes in breast cancer, with ongoing projects such as spheroid and organoid analyses, as well as active cell-based computational modelling. We also have a number of other research topics spanning muscle atrophy, immune cell mechanobiology, and soft tissue biomechanics.
“Breast cancer remains the second most common cause of cancer-related death in Irish women. This project will develop a new way to diagnose and treat cancer by analysing the physical forces that contribute to tumour growth and drug resistance. By creating computer models and analysing tissue from cancer patients, our team will develop a better understanding of how physical pressure can both prevent tumour progression and reduce drug efficacy. Ultimately, the project aims to create a personalised healthcare tool to predict cancer and treatment outcomes, leading to more effective patient-specific diagnosis and treatment.” – Dr Eoin McEvoy, Associate Professor in Biomedical Engineering, University of Galway
Two University of Galway academic researchers have secured prestigious grant awards from the European Research Council to pursue scientific research on evolution and breast cancer [. . .] The scientists are among eight academics and researchers based in Ireland to be approved for an ERC Starting Grant 2023 and among 400 across Europe. ERC Starting Grants are awarded over a five year period. Read more in the press release here.
